Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Met nieuwe leidraad multimorbiditeit op weg naar toekomstbestendige zorg
okt 2024